Alcidion (ASX:ALC) was founded in Adelaide in 2000 with the aim of driving meaningful change in health outcomes with smart technology and joined the ASX in January 2016. ALC aims to deliver value to existing patient and clinician information systems by aggregating the data available in healthcare systems, centralising it in the company’s Miya Precision platform, and using that data to support health professionals in their clinical decision-making. ALC has expanded organically and by acquisition into the Australian, New Zealand and UK markets with a significant step-up in the UK since acquiring MKM Health in 2018. ALC went on to acquire Silverlink in December 2021 funded by a $55m capital raising. Silverlink is a Patient Administration System (PAS) provider serving the UK NHS. Alcidion’s main products include Miya Precision – a platform which delivers a suite of flexible modules allowing consolidation of patient information from disparate sources, and Smartpage, a secure smartphone and web-based system for hospital communication and task management which facilitates clear and secure patient handover as well as management of non-clinical patient services. A key issue underpinning Alcidion’s proposition is a significant increase in patient-related data which hospital systems grappling with legacy IT have struggled to handle. In FY22 ALC has renewed and acquired significant contracts with Australian health systems and UK NHS Trusts resulting in a 42% increase in recurring revenue.
08 Nov 2022
Breaking through in the UK's NHS
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Breaking through in the UK's NHS
Alcidion (ASX:ALC) was founded in Adelaide in 2000 with the aim of driving meaningful change in health outcomes with smart technology and joined the ASX in January 2016. ALC aims to deliver value to existing patient and clinician information systems by aggregating the data available in healthcare systems, centralising it in the company’s Miya Precision platform, and using that data to support health professionals in their clinical decision-making. ALC has expanded organically and by acquisition into the Australian, New Zealand and UK markets with a significant step-up in the UK since acquiring MKM Health in 2018. ALC went on to acquire Silverlink in December 2021 funded by a $55m capital raising. Silverlink is a Patient Administration System (PAS) provider serving the UK NHS. Alcidion’s main products include Miya Precision – a platform which delivers a suite of flexible modules allowing consolidation of patient information from disparate sources, and Smartpage, a secure smartphone and web-based system for hospital communication and task management which facilitates clear and secure patient handover as well as management of non-clinical patient services. A key issue underpinning Alcidion’s proposition is a significant increase in patient-related data which hospital systems grappling with legacy IT have struggled to handle. In FY22 ALC has renewed and acquired significant contracts with Australian health systems and UK NHS Trusts resulting in a 42% increase in recurring revenue.